Blood test for early detection of congenital heart disease (CHD)
Diagnostic
Congenital heart diseases (CHD), in which a baby’s heart does not develop properly, can be severe and life-threatening.
Many of them require surgery to correct. However, current methods only allow detection of CHDs once the heart has already developed in the second trimester. This study will explore whether certain biological markers in the mother’s blood can be an early indicator of the development of CHD.
If so, this could improve understanding of CHD and how to detect them earlier.
The development of a new AI-supported model for imaging the heart based on data from over 700 people with atrial fibrillation, allow ablation to be more personalised to individual patients.
Cardiac patches for heart repair
A trial for every patient
Personalised angina care
Your gifts fund our life saving project